Cary Street Partners Investment Advisory’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-676
Closed -$61.1K – 787
2026
Q1
$61.1K Buy
+676
New +$62K 0.02% 516
2025
Q4
– Sell
-219
Closed -$21.6K – 706
2025
Q3
$21.6K Sell
219
-108
-33% -$10.7K 0.01% 507
2025
Q2
$29.8K Buy
327
+149
+84% +$14.4K 0.01% 457
2025
Q1
$20.1K Sell
178
-125
-41% -$13.4K 0.01% 442
2024
Q4
$32K Sell
303
-9,221
-97% -$989K 0.02% 364
2024
Q3
$1.03M Buy
9,524
+807
+9% +$88.1K 0.04% 365
2024
Q2
$946K Buy
8,717
+115
+1% +$13.6K 0.04% 350
2024
Q1
$1.14M Buy
8,602
+281
+3% +$35.1K 0.05% 323
2023
Q4
$1.01M Sell
8,321
-266
-3% -$29.7K 0.05% 318
2023
Q3
$964K Buy
8,587
+7,148
+497% +$908K 0.05% 306
2023
Q2
$210K Sell
1,439
-115
-7% -$15.6K 0.01% 499
2023
Q1
$201K Sell
1,554
-220
-12% -$27.6K 0.01% 469
2022
Q4
$226K Sell
1,774
-165
-9% -$19.1K 0.02% 446
2022
Q3
$203K Buy
1,939
+575
+42% +$63.1K 0.02% 448
2022
Q2
$143K Buy
+1,364
New +$162K 0.01% 472
2021
Q3
– Sell
-367
Closed -$57K – 314
2021
Q2
$57K Hold
367
– – 0.02% 284
2021
Q1
$57K Sell
367
-1,382
-79% -$214K 0.02% 263
2020
Q4
$262K Sell
1,749
-4,196
-71% -$593K 0.05% 273
2020
Q3
$786K Buy
+5,945
New +$777K 0.17% 147

Other funds holding ZBH

Cary Street Partners Investment Advisory's ZBH Position: Q2 2026 in Review

Cary Street Partners Investment Advisory sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 676 shares — an estimated $61.1K sold.

Cary Street Partners Investment Advisory first reported a position in ZBH in Q3 2020 and held it in 19 quarters. The position peaked at $1.14M in Q1 2024. 911 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Cary Street Partners Investment Advisory reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 676 Zimmer Biomet shares in Q2 2026, an estimated $61.1K.
  • Cary Street Partners Investment Advisory first reported a position in Zimmer Biomet in Q3 2020 and held it in 19 quarters.
  • Cary Street Partners Investment Advisory's Zimmer Biomet position peaked at $1.14M in Q1 2024.
  • 911 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.